Clinical Trial Update: ITM11 Expanded Access Program

View source ↗

Summary

The ITM11 expanded access program for meningioma is currently available, allowing eligible patients to access the investigational product outside a formal trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• ITM11

Snippet

Sponsor: ITM Solucin GmbH | Conditions: Meningioma | Status: AVAILABLE